{"gene":"CD53","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1990,"finding":"CD53 is a 219-amino acid type III integral membrane protein with four transmembrane domains and N-glycosylation sites, constituting the structural basis of the tetraspanin family; it is the human homologue of rat OX-44.","method":"cDNA cloning, sequence analysis, immunoprecipitation of transfected cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — original molecular characterization by two independent groups using cDNA cloning and expression","pmids":["2258620","1700763"],"is_preprint":false},{"year":1993,"finding":"Cross-linking of CD53 on human B cells, monocytes, and granulocytes triggers cytoplasmic calcium fluxes and activates the monocyte oxidative burst; signaling is largely independent of protein kinase C but sensitive to high-dose staurosporine and dependent on tyrosine kinases rather than GTP-binding proteins.","method":"Cross-linking of cell-bound F(ab')2 anti-CD53 mAb; calcium flux assay; oxidative burst assay; pharmacological inhibitors (staurosporine, ADP-ribosylating toxins)","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal functional assays with defined pharmacological dissection","pmids":["8335905"],"is_preprint":false},{"year":1993,"finding":"The major extracellular (hydrophilic) loop of CD53 contains epitopes recognized by anti-CD53 mAbs (OX-44, 2D1, 6E2, 7D2), and these epitopes are sensitive to reduction, demonstrating the importance of disulfide bonding in the correct folding of the CD53 extracellular domain and directly confirming the four-transmembrane topology.","method":"Epitope mapping using GST-fusion chimeric proteins and anti-rat CD53 mAbs; reduction sensitivity assays","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — direct molecular epitope mapping with mutagenesis-equivalent chimeric proteins","pmids":["7678222"],"is_preprint":false},{"year":1994,"finding":"CD53 (together with CD37, TAPA-1/CD81, and R2/C33) co-precipitates with MHC class II (DR) glycoproteins from B cell lysates in mild detergent, forming large multicomponent complexes on the B cell surface.","method":"Co-immunoprecipitation and preclearing experiments from human B-cell line and tonsillar B cell lysates","journal":"Immunogenetics","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-immunoprecipitation replicated across cell types","pmids":["8119731"],"is_preprint":false},{"year":1994,"finding":"Activation of CD53 in rat macrophages by antibody cross-linking increases inositol phosphates, diacylglycerol, and intracellular Ca2+ (insensitive to pertussis/cholera toxins), leads to protein kinase C translocation to the membrane, and induces expression of inducible nitric oxide synthase (iNOS) resulting in nitric oxide release in a PKC- and protein synthesis-dependent manner.","method":"Antibody cross-linking; inositol phosphate and diacylglycerol measurement; Ca2+ mobilization; PKC translocation assay; NO measurement; iNOS expression analysis; pharmacological inhibitors","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal biochemical assays defining a complete signaling pathway","pmids":["7511680"],"is_preprint":false},{"year":1994,"finding":"Cross-linking of CD53 on resting human B lymphocytes promotes their entry into G1 phase (increased CD69, cell volume, RNA synthesis, c-myc levels), and in combination with cytokines (IL-2, IL-4) induces DNA synthesis and immunoglobulin production.","method":"Anti-CD53 mAb cross-linking; flow cytometry; RNA synthesis measurement; c-myc immunoblot; [3H]thymidine incorporation; Ig ELISA","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal readouts of B cell activation with defined costimulatory context","pmids":["7963560"],"is_preprint":false},{"year":1995,"finding":"Immune complexes of rat CD53 contain tyrosine phosphatase activity capable of dephosphorylating Lck in vitro; the phosphatase is distinct from CD45 and is inhibited by tyrosine phosphatase inhibitors. CD63 similarly co-precipitates a phosphatase.","method":"Immunoprecipitation from lymph node and thymoma lysates; in vitro phosphatase activity assay on phospho-Lck and synthetic substrate; depletion experiments; phosphatase inhibitor treatment","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro enzyme activity assay, but identity of the phosphatase not established","pmids":["7621882"],"is_preprint":false},{"year":1996,"finding":"CD53, CD82, CD63, and CD81 specifically associate with integrin α4β1 (VLA-4/CD49d/CD29) on hematopoietic cell lines, as shown by reciprocal co-immunoprecipitation; the association is independent of the α4 cytoplasmic domain and divalent cations but is lost in two α4 adhesion-deficient mutants (D346E and D408E).","method":"Reciprocal co-immunoprecipitation; confocal microscopy; mutant integrin transfectants; divalent cation chelation","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with mutational dissection replicated across multiple cell lines","pmids":["8757325"],"is_preprint":false},{"year":1996,"finding":"CD53, CD81, and CD82 are in close proximity (2–10 nm) to MHC class II (DR, DQ), MHC class I, and CD20 on B cell surfaces, forming supramolecular complexes; FRET analysis suggests all these molecules participate in a single multi-component assembly.","method":"Flow cytometric FRET (fluorescence energy transfer) with fluorescently labeled mAbs","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — biophysical FRET approach with quantitative distance constraints","pmids":["8816400"],"is_preprint":false},{"year":1997,"finding":"CD53 ligation on lymphoma B cells (rat IR938F) induces homotypic adhesion that requires divalent cations (Ca2+, Mg2+), de novo protein synthesis, and is mediated by tyrosine kinase (genistein/piceatannol-sensitive), PI3K (wortmannin-sensitive), and PKC (H7/bisindolylmaleimide-sensitive) signaling pathways, but is LFA-1-independent; electron microscopy reveals localized membrane contact zones.","method":"Anti-CD53 mAb cross-linking; cell aggregation assay; pharmacological inhibitors (genistein, piceatannol, wortmannin, H7, bisindolylmaleimide, cycloheximide, actinomycin D, EGTA/EDTA); immunoelectron microscopy","journal":"Cellular immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple pathway inhibitors with orthogonal structural readout","pmids":["9225004"],"is_preprint":false},{"year":1997,"finding":"Anti-CD53 mAb induces homotypic aggregation of lymphoid cell lines via both LFA-1/ICAM-1-dependent and -independent pathways; aggregation is energy-dependent and partially blocked by anti-LFA-1 or anti-ICAM-1, but not by anti-CD44 or anti-CD49d mAbs.","method":"Anti-CD53 mAb cross-linking; blocking mAb experiments; cell aggregation assay including a LAD patient B cell line lacking LFA-1","journal":"Immunobiology","confidence":"Medium","confidence_rationale":"Tier 2 — use of LAD patient cells as genetic control for LFA-1 independence","pmids":["9241532"],"is_preprint":false},{"year":1997,"finding":"Anti-CD53 mAb (like anti-CD9, anti-CD81, anti-CD82 mAbs) delivers a costimulatory signal for CD3-mediated T cell activation and inhibits migration of megakaryocytic and pre-B cell lines, consistent with CD53 participation in a tetraspan network.","method":"mAb cross-linking; T cell costimulation assay; homotypic aggregation and migration inhibition assays in HEL and NALM-6 cell lines","journal":"Cellular immunology","confidence":"Medium","confidence_rationale":"Tier 2 — parallel comparison of four tetraspanins in same assay","pmids":["9514697"],"is_preprint":false},{"year":1998,"finding":"Physiological neutrophil activators (TNFα, PAF, fMLP, PMA, ionomycin) cause down-regulation of CD53 from the neutrophil cell surface via a proteolytic mechanism (inhibited by PMSFP), without changes in CD53 transcript levels.","method":"Flow cytometry; immunoblotting; pharmacological inhibition (PMSF); Northern/RT analysis","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple activators and orthogonal protein/mRNA analysis","pmids":["9620662"],"is_preprint":false},{"year":2002,"finding":"Ligation of CD53 (rat or human) induces a transient 3–4-fold activation of JNK that peaks at 3–5 min in B-cell lymphoma and T-cell lymphoma lines, and in a renal carcinoma line transiently transfected with human CD53; this JNK activation is independent of Vav and sufficient to stimulate Jun-dependent transcription.","method":"Anti-CD53 mAb cross-linking; in vitro JNK kinase assay (endogenous and exogenous); Jun-dependent transcriptional reporter; Vav co-stimulation assay","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — kinase activity assay across multiple cell lines with genetic dissection from Vav","pmids":["11846804"],"is_preprint":false},{"year":2003,"finding":"CD53 ligation on tumor B and T cells (IR938F, Jurkat) reduces apoptosis induced by serum deprivation, decreases caspase activation and DNA fragmentation, increases Bcl-xL and decreases Bax, and activates AKT (phosphorylation at Ser473).","method":"Anti-CD53 mAb cross-linking; PARP cleavage assay; DNA fragmentation assay; Bcl-xL/Bax immunoblot; AKT phosphorylation immunoblot","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal apoptosis readouts with defined AKT mechanistic link","pmids":["12606948"],"is_preprint":false},{"year":2003,"finding":"CD53 ligation in rat mesangial cells triggers DNA synthesis via ERK1/ERK2 activation (blocked by PD98059/MEK inhibitor), but not through PI3K, PKC, or calcium channel pathways; CD53 is expressed in mesangial cells in vivo.","method":"Anti-CD53 mAb cross-linking; [3H]thymidine incorporation; ERK phosphorylation by immunoblot; pharmacological inhibitors (PD98059, wortmannin, PKC inhibitors, thapsigargin, verapamil); flow cytometry for apoptosis","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 — pathway dissection with specific MEK inhibitor and multiple negative controls","pmids":["12631118"],"is_preprint":false},{"year":2004,"finding":"CD53 overexpression in macrophages increases intracellular GSH, lowers peroxide levels, and confers resistance to H2O2 and UVB irradiation; antisense CD53 has the opposite effects; CD53 is induced by LPS and nitric oxide (SNAP) in macrophages.","method":"Stable sense and antisense CD53 transfection; GSH measurement; peroxide assay; H2O2 and UVB cell viability assays; Northern blot; microarray","journal":"Molecules and cells","confidence":"Medium","confidence_rationale":"Tier 2 — gain- and loss-of-function with multiple biochemical readouts","pmids":["15055538"],"is_preprint":false},{"year":2007,"finding":"In macrophages, HIV-1 buds into an intracellular plasma membrane domain containing tetraspanins CD81, CD9, and CD53 (not classic endosomes); this compartment is connected to the cell surface (accessible to extracellular tracers at 4°C) and lacks endosome markers including CD63.","method":"Immunofluorescence microscopy; immunoelectron microscopy; horseradish peroxidase and ruthenium red tracer accessibility assays; marker co-localization","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — multiple imaging modalities with direct biochemical accessibility assay","pmids":["17438075"],"is_preprint":false},{"year":2007,"finding":"CD53 gene expression is directly regulated by the transcription factor EBF1; functional EBF1 binding sites are present in the CD53 promoter and EBF1 expression drives CD53 transcription in transient transfection assays.","method":"Retroviral EBF1 transduction of BaF/3 cells; microarray; promoter 5' end mapping; transient transfection transcriptional assays","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — promoter functional analysis with gain-of-function in hematopoietic progenitor cells","pmids":["17429843"],"is_preprint":false},{"year":2013,"finding":"CD53 knockdown by siRNA in THP-1 monocytic cells stimulated with house dust mite significantly increases production of inflammatory cytokines and NFκB activity, demonstrating that CD53 suppresses over-activation of inflammatory cytokine responses.","method":"siRNA knockdown; cytokine ELISA; NFκB activity assay","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — RNAi loss-of-function with signaling pathway readout","pmids":["23313165"],"is_preprint":false},{"year":2014,"finding":"CD53 ligation on rat NK cells reduces degranulation and IFNγ responses to activating NK receptors (Ly49s3, NKR-P1A, NKp46), induces activation of the β2 integrin LFA-1, promotes homotypic NK cell adhesion, and enhances NK cell proliferation in response to IL-2.","method":"Anti-CD53 mAb cross-linking; degranulation assay; redirected killing assay; IFNγ ELISA; LFA-1 activation flow cytometry; proliferation assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays in primary NK cells","pmids":["24832104"],"is_preprint":false},{"year":2019,"finding":"CD53 physically interacts with IL-7Rα and promotes IL-7 signaling (PI3K and JAK/STAT pathways) in developing B cells; loss of CD53 reduces IL-7Rα surface expression, increases apoptosis in pro-B cells, and blocks the pro-B to pre-B transition.","method":"Co-immunoprecipitation; proximity ligation assay; flow cytometry for IL-7Rα; phospho-flow for PI3K and JAK/STAT; apoptosis assays; mixed bone marrow chimeras","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — physical interaction confirmed by two methods (Co-IP + PLA) with cell-autonomous KO phenotype","pmids":["31748347"],"is_preprint":false},{"year":2020,"finding":"CD53 stabilizes L-selectin surface expression on B and T cells, restrains L-selectin shedding via both ADAM17-dependent and ADAM17-independent mechanisms, and is required for efficient lymphocyte homing to lymph nodes; Cd53−/− mice have markedly smaller lymph nodes due to reduced B and T cell homing.","method":"Cd53−/− mouse analysis; flow cytometry for L-selectin; adoptive transfer homing assays; ADAM17 inhibitor experiments; in vivo lymph node cellularity","journal":"iScience","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with multiple orthogonal assays and defined molecular mechanism (L-selectin/ADAM17)","pmids":["32428859"],"is_preprint":false},{"year":2020,"finding":"CD53 restrains α3 integrin mobilization in neutrophils, promotes cytoskeletal remodeling and transendothelial migration; Cd53−/− neutrophils show defective transmigration across endothelium in response to TNF, CXCL1, and CCL2, and near-complete absence of L-selectin.","method":"Cd53−/− mouse; intravital microscopy; peritoneal inflammation model; flow cytometry for adhesion molecules and integrins; cytoskeletal remodeling assays; serum-induced arthritis model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — intravital imaging plus multiple in vivo inflammatory models with defined molecular correlates","pmids":["32532837"],"is_preprint":false},{"year":2022,"finding":"CD53 interacts with CD45 (identified by unbiased mass spectrometry) and is required for CD45RO isoform expression, CD45 membrane stability and mobility, and optimal CD45 phosphatase activity, leading to Lck activation; Cd53−/− T cells show proliferation defects and impaired tumor rejection.","method":"Unbiased mass spectrometry; proximity ligation assay; FRAP (fluorescence recovery after photobleaching); phosphatase activity assay; Lck activation immunoblot; in vivo tumor rejection model; IFNγ ELISPOT","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1–2 — unbiased proteomics, biophysical membrane analysis, enzymatic activity, and in vivo functional validation","pmids":["35767951"],"is_preprint":false},{"year":2022,"finding":"CD53 integrates inflammatory and metabolic signals in hepatocytes; CD53 deletion blocks Western diet-induced dyslipidemia, hepatic inflammatory gene expression, and triglyceride accumulation; CD53 deletion attenuates TNFα- and fatty acid+LPS-induced cytokine expression in isolated hepatocytes.","method":"Germline CD53 KO mice; Western diet feeding; NASH diet model; primary hepatocyte isolation; cytokine gene expression; triglyceride assay; glucose transporter 8 deletion and trehalose treatment as comparators","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse plus isolated hepatocyte experiments with multiple dietary/inflammatory models","pmids":["36581203"],"is_preprint":false},{"year":2023,"finding":"CD53 interacts with DREAM complex-associated proteins, specifically promoting the interaction between Rbl2/p130 and its phosphatase PP2A, stabilizing p130 for DREAM complex assembly; this promotes HSC quiescence following inflammatory stress, and loss of CD53 leads to prolonged cycling and reduced HSC function.","method":"Proximity labeling proteomics; confocal fluorescence microscopy; DREAM complex co-immunoprecipitation; PP2A-p130 interaction assay; Cd53−/− HSC cell cycle analysis; 5-FU stress model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — proximity labeling plus co-IP for molecular mechanism, with in vivo KO validation","pmids":["36542833"],"is_preprint":false},{"year":2023,"finding":"Glycosylation of CD53 inhibits its interaction with partner proteins CD45, CD20, and CD37; abrogation of CD53 glycosylation does not affect surface expression but increases interaction with partners. CD37 glycosylation is required for its surface expression, while CD53 glycosylation controls partner protein interaction capacity.","method":"Glycosylation mutant generation; surface expression flow cytometry; single-molecule dSTORM super-resolution microscopy; co-immunoprecipitation","journal":"Biophysical journal","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with super-resolution imaging and Co-IP","pmids":["38031400"],"is_preprint":false},{"year":2024,"finding":"CD53 physically interacts with CXCR4 (confirmed by proximity ligation assay) and promotes CXCL12-induced CXCR4 signaling and receptor internalization; Cd53−/− B cells show reduced CXCL12 migration in vitro and impaired bone marrow homing in vivo.","method":"Proximity ligation assay; in vitro migration assay; CXCR4 signaling (phospho-flow); CXCR4 internalization assay; in vivo homing assay in Cd53−/− mice","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — physical interaction by PLA combined with functional receptor assays and in vivo validation","pmids":["38363205"],"is_preprint":false},{"year":2024,"finding":"The 'closed' conformational mutant of CD53 (F44E) shows increased clustering in nanodomains and greater interaction with its partner CD45 compared to wild-type CD53; absence of CD53 increases CD45 clustering tendency, indicating CD53 conformation regulates its nanoscale membrane organization and partner interactions.","method":"Conformational mutant generation (F44E); super-resolution dSTORM microscopy; co-immunoprecipitation; CD53 KO B cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1–2 — structure-function mutagenesis with super-resolution imaging","pmids":["39159818"],"is_preprint":false},{"year":2025,"finding":"CD53 promotes ROS-induced neutrophil extracellular trap (NET) formation via modulation of the PI3K/AKT pathway; anti-CD53 neutralizing antibody inhibits NET formation in vitro and reduces inflammatory injury in a caerulein-induced acute pancreatitis mouse model.","method":"PMA-induced in vitro NET model; anti-CD53 neutralizing antibody; PI3K/AKT pathway analysis; caerulein AP mouse model; NET quantification in tissues","journal":"Journal of inflammation research","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo loss-of-function with defined signaling pathway","pmids":["40098997"],"is_preprint":false}],"current_model":"CD53 is a leukocyte-restricted four-transmembrane tetraspanin that organizes plasma membrane microdomains and acts as a signaling scaffold: it physically associates with MHC class II, integrins (α4β1, α3), L-selectin, IL-7Rα, CXCR4, CD45, and other tetraspanins to regulate lymphocyte homing (via L-selectin stabilization and ADAM17 restraint), early B cell development (via IL-7R/PI3K/JAK-STAT signaling), T cell activation (via CD45RO stability and Lck activation), NK cell effector/proliferative balance (via LFA-1 activation), HSC quiescence (via PP2A–p130/DREAM complex), and myeloid cell transmigration and inflammatory cytokine responses; its ligation triggers calcium flux, PKC translocation, iNOS/NO production, AKT-mediated survival, JNK activation, and ERK-dependent proliferation, with glycosylation and conformational state providing additional layers of regulation."},"narrative":{"teleology":[{"year":1990,"claim":"Establishing CD53 as a founding tetraspanin resolved its four-transmembrane topology and N-glycosylation, providing the structural framework for understanding how it scaffolds membrane complexes.","evidence":"cDNA cloning and sequence analysis of human CD53 and its rat homologue OX-44","pmids":["2258620","1700763"],"confidence":"High","gaps":["No crystal or cryo-EM structure of CD53","Stoichiometry of CD53 in membrane complexes unknown"]},{"year":1993,"claim":"Demonstrating that CD53 cross-linking triggers calcium flux and tyrosine kinase-dependent signaling established CD53 as an active signaling molecule rather than a passive structural component.","evidence":"Anti-CD53 F(ab')2 cross-linking on B cells, monocytes, granulocytes with calcium flux and pharmacological inhibitors; disulfide-dependent epitope mapping on extracellular loop","pmids":["8335905","7678222"],"confidence":"High","gaps":["Identity of the proximal tyrosine kinase not determined","Physiological ligand unknown"]},{"year":1994,"claim":"Discovery that CD53 co-precipitates with MHC class II and other tetraspanins on B cells, and that its ligation induces PKC translocation, iNOS/NO production in macrophages, and B cell activation (G1 entry, Ig secretion), positioned CD53 as a central organizer of immune cell surface signaling platforms.","evidence":"Co-immunoprecipitation from B cell lysates; anti-CD53 cross-linking with PKC, iNOS, calcium, and B cell activation readouts","pmids":["8119731","7511680","7963560"],"confidence":"High","gaps":["Whether CD53 directly contacts MHC class II or requires bridging tetraspanins not resolved","Relative contribution of PKC versus tyrosine kinase arms to macrophage NO production unclear"]},{"year":1996,"claim":"Reciprocal co-immunoprecipitation with integrin α4β1 and FRET-based proximity mapping with MHC class I/II and CD20 established that CD53 participates in multi-component supramolecular assemblies organized at nanometer scale on leukocyte surfaces.","evidence":"Reciprocal co-IP with mutant integrin dissection; flow cytometric FRET on B cells","pmids":["8757325","8816400"],"confidence":"High","gaps":["Whether complexes are pre-formed or activation-dependent not fully resolved","Contribution of lipid composition to complex stability unknown"]},{"year":1997,"claim":"Pathway dissection of CD53-induced homotypic adhesion revealed that CD53 engages tyrosine kinase, PI3K, and PKC cascades to drive adhesion through both LFA-1-dependent and -independent routes, indicating CD53 can activate multiple downstream effector modules simultaneously.","evidence":"Anti-CD53 cross-linking with pharmacological inhibitors (genistein, wortmannin, PKC inhibitors); LAD patient cells lacking LFA-1; immunoelectron microscopy","pmids":["9225004","9241532","9514697"],"confidence":"Medium","gaps":["LFA-1-independent adhesion molecule not identified","Whether CD53-induced adhesion occurs via inside-out integrin signaling not directly tested"]},{"year":2002,"claim":"Identification of JNK as a rapid downstream effector of CD53 ligation, independent of Vav, extended the signaling repertoire beyond calcium/PKC and linked CD53 to Jun-dependent transcriptional programs.","evidence":"In vitro JNK kinase assay after anti-CD53 cross-linking in B and T cell lymphoma lines; Jun-dependent reporter","pmids":["11846804"],"confidence":"Medium","gaps":["Upstream kinase coupling CD53 to JNK not identified","In vivo relevance of CD53-JNK axis not tested"]},{"year":2003,"claim":"Connecting CD53 to AKT-mediated survival signaling (Bcl-xL upregulation, Bax downregulation) and ERK-dependent proliferation in mesangial cells broadened CD53 function beyond immune activation to include cytoprotection and mitogenesis.","evidence":"Anti-CD53 cross-linking with AKT phosphorylation, apoptosis readouts in lymphoma cells; ERK phosphorylation and thymidine incorporation with MEK inhibitor in mesangial cells","pmids":["12606948","12631118"],"confidence":"High","gaps":["How CD53 selectively activates AKT versus ERK in different cell types not explained","Mesangial cell findings lack genetic loss-of-function validation"]},{"year":2007,"claim":"Localization of CD53 to macrophage intracellular plasma membrane compartments used by HIV-1 for budding revealed a role for CD53-enriched domains in pathogen biology, while identification of EBF1 as a transcriptional regulator placed CD53 expression under B-lineage developmental control.","evidence":"Immunoelectron microscopy and tracer accessibility in macrophages; EBF1 retroviral transduction and promoter analysis","pmids":["17438075","17429843"],"confidence":"High","gaps":["Whether CD53 actively facilitates or restricts HIV budding not determined","Whether other transcription factors cooperate with EBF1 for CD53 induction not tested"]},{"year":2019,"claim":"Using Cd53-knockout mice and proximity ligation, the demonstration that CD53 physically stabilizes IL-7Rα to promote PI3K and JAK-STAT signaling provided the first in vivo genetic evidence that CD53 is essential for a specific developmental checkpoint — the pro-B to pre-B transition.","evidence":"Co-IP and PLA for CD53–IL-7Rα; phospho-flow; apoptosis assays; mixed bone marrow chimeras in Cd53−/− mice","pmids":["31748347"],"confidence":"High","gaps":["Whether CD53 regulates IL-7Rα recycling or solely surface retention not distinguished","Structural basis of CD53–IL-7Rα interaction unknown"]},{"year":2020,"claim":"Cd53−/− mouse studies revealed that CD53 stabilizes L-selectin by restraining ADAM17-mediated shedding and modulates α3 integrin in neutrophils, establishing CD53 as a master regulator of leukocyte trafficking to lymph nodes and inflammatory sites.","evidence":"Cd53−/− adoptive transfer homing assays; ADAM17 inhibitor experiments; intravital microscopy; peritoneal inflammation and arthritis models","pmids":["32428859","32532837"],"confidence":"High","gaps":["Direct binding interface between CD53 and L-selectin or ADAM17 not mapped","Whether CD53 physically sequesters ADAM17 or acts indirectly not resolved"]},{"year":2022,"claim":"Unbiased mass spectrometry identified CD45 as a key CD53 partner, and functional studies showed CD53 is required for CD45RO isoform expression, CD45 membrane mobility, and Lck activation — linking CD53 to the core TCR proximal signaling apparatus and explaining impaired anti-tumor T cell responses in Cd53−/− mice.","evidence":"Mass spectrometry; PLA; FRAP; phosphatase activity assay; in vivo tumor rejection in Cd53−/− mice","pmids":["35767951"],"confidence":"High","gaps":["Whether CD53 influences CD45 alternative splicing or post-translational processing not distinguished","Mechanism by which CD53 controls CD45 membrane dynamics not elucidated"]},{"year":2022,"claim":"Extension of CD53 function beyond hematopoietic cells: CD53 deletion in hepatocytes attenuated Western diet-induced dyslipidemia and inflammatory gene expression, indicating CD53 integrates inflammatory and metabolic signals in non-immune cells.","evidence":"Germline CD53 KO mice on Western/NASH diets; primary hepatocyte cytokine and triglyceride assays","pmids":["36581203"],"confidence":"Medium","gaps":["Cell-type-specific conditional KO not used; hepatocyte-autonomous role versus secondary immune effects not fully separated","Hepatocyte signaling partners of CD53 not identified"]},{"year":2023,"claim":"Discovery that CD53 scaffolds the PP2A–p130 interaction to stabilize the DREAM complex and promote HSC quiescence after inflammatory stress revealed a novel non-canonical tetraspanin function in stem cell biology.","evidence":"Proximity labeling proteomics; PP2A–p130 co-IP; Cd53−/− HSC cell cycle analysis after 5-FU stress","pmids":["36542833"],"confidence":"High","gaps":["Whether CD53 directly binds PP2A or p130 not determined","Whether this mechanism operates in other quiescent cell types unknown"]},{"year":2023,"claim":"Glycosylation and conformational state emerged as regulatory layers: N-glycosylation of CD53 inhibits partner interactions (CD45, CD20, CD37) without affecting surface expression, and a closed-conformation mutant (F44E) shows enhanced clustering and CD45 binding, establishing that CD53 function is dynamically tunable.","evidence":"Glycosylation-site mutants with dSTORM super-resolution microscopy and co-IP; F44E conformational mutant analysis","pmids":["38031400","39159818"],"confidence":"Medium","gaps":["Physiological signals that regulate CD53 glycosylation or conformational switching in vivo unknown","No structural data for open versus closed CD53 conformations"]},{"year":2024,"claim":"Identification of CXCR4 as a CD53 interaction partner and demonstration that CD53 promotes CXCR4 signaling and internalization extended the receptor-stabilization paradigm to chemokine receptors and explained impaired B cell bone marrow homing in Cd53−/− mice.","evidence":"PLA for CD53–CXCR4; CXCR4 phospho-flow and internalization; in vivo homing assay in Cd53−/− mice","pmids":["38363205"],"confidence":"High","gaps":["Whether CD53 similarly modulates other chemokine receptors not tested","Mechanism of CXCR4 internalization enhancement not defined"]},{"year":null,"claim":"Key unresolved questions include the identity of a physiological extracellular ligand for CD53, the atomic structure of CD53 and its partner complexes, the signals controlling conformational switching in vivo, and whether the receptor-stabilization mechanism generalizes across all CD53 partners.","evidence":"","pmids":[],"confidence":"High","gaps":["No physiological ligand identified","No high-resolution structure available","In vivo regulation of CD53 conformation and glycosylation state unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[3,7,8,21,22,24,26,28]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[19,22,24,26]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,7,8,17,22,27,29]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[17]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,4,5,11,19,20,21,22,23,24,28,30]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,4,13,14,15,21,24,26]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[9,10,22,23]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[21,26]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[14,16]}],"complexes":["Tetraspanin-enriched microdomain (TEM)","MHC class II–tetraspanin complex","PP2A–p130/DREAM complex"],"partners":["CD45","IL7R","CXCR4","SELL","ITGA4","CD81","RBL2","PPP2CA"],"other_free_text":[]},"mechanistic_narrative":"CD53 is a leukocyte-enriched tetraspanin that organizes plasma membrane signaling platforms to regulate lymphocyte trafficking, activation, and innate immune cell inflammatory responses. It physically associates with MHC class II, integrins (α4β1, α3), L-selectin, IL-7Rα, CXCR4, and CD45, stabilizing these partners at the cell surface and modulating their signaling output: CD53 promotes IL-7R/PI3K/JAK-STAT signaling required for the pro-B to pre-B transition [PMID:31748347], stabilizes L-selectin to enable lymphocyte homing to lymph nodes [PMID:32428859], sustains CD45RO isoform expression and Lck activation for T cell proliferation and anti-tumor immunity [PMID:35767951], and facilitates CXCR4-driven B cell migration and bone marrow homing [PMID:38363205]. Beyond adaptive immunity, CD53 ligation activates calcium flux, PKC, JNK, ERK, and AKT pathways in myeloid and mesangial cells [PMID:7511680, PMID:12606948, PMID:12631118], restrains inflammatory cytokine production via NF-κB suppression [PMID:23313165], promotes neutrophil transendothelial migration and NET formation [PMID:32532837, PMID:40098997], and maintains hematopoietic stem cell quiescence by scaffolding the PP2A–p130/DREAM complex [PMID:36542833]."},"prefetch_data":{"uniprot":{"accession":"P19397","full_name":"Leukocyte surface antigen CD53","aliases":["Cell surface glycoprotein CD53","Tetraspanin-25","Tspan-25"],"length_aa":219,"mass_kda":24.3,"function":"Structural component of specialized membrane microdomains known as tetraspanin-enriched microdomains (TERMs), which act as platforms for receptor clustering and signaling (PubMed:28487417). Participates thereby in diverse biological functions such as cell signal transduction, adhesion, migration and protein trafficking (PubMed:32974937, PubMed:35767951). Plays a role in the activation of monocytes and B-cells (PubMed:8335905). Acts as an essential regulator of B-cell development by promoting interleukin-7 receptor/IL7R signaling (By similarity). Also promotes, in B-cells, the BCR signaling by recruiting PKC to the plasma membrane in order to phosphorylate its substrates (PubMed:28487417). Plays an essential role in B- and T-cells homing to lymph nodes by stabilizing L-selectin/SELL cell surface expression (By similarity). Also mediates metabolic and inflammatory functions in hepatocytes and adipose tissue by promoting TNF and LPS signaling independent of the immune compartment (By similarity)","subcellular_location":"Cell membrane; Cell junction; Membrane; Synapse","url":"https://www.uniprot.org/uniprotkb/P19397/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CD53","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CD53","total_profiled":1310},"omim":[{"mim_id":"614406","title":"SLP ADAPTOR- AND CSK-INTERACTING MEMBRANE PROTEIN; SCIMP","url":"https://www.omim.org/entry/614406"},{"mim_id":"604516","title":"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 2; IGSF2","url":"https://www.omim.org/entry/604516"},{"mim_id":"602380","title":"UROPLAKIN 1B; UPK1B","url":"https://www.omim.org/entry/602380"},{"mim_id":"600623","title":"CD82 ANTIGEN; CD82","url":"https://www.omim.org/entry/600623"},{"mim_id":"181035","title":"TETRASPANIN 31; TSPAN31","url":"https://www.omim.org/entry/181035"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":419.9}],"url":"https://www.proteinatlas.org/search/CD53"},"hgnc":{"alias_symbol":["TSPAN25"],"prev_symbol":["MOX44"]},"alphafold":{"accession":"P19397","domains":[{"cath_id":"-","chopping":"1-219","consensus_level":"medium","plddt":93.3437,"start":1,"end":219}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P19397","model_url":"https://alphafold.ebi.ac.uk/files/AF-P19397-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P19397-F1-predicted_aligned_error_v6.png","plddt_mean":93.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CD53","jax_strain_url":"https://www.jax.org/strain/search?query=CD53"},"sequence":{"accession":"P19397","fasta_url":"https://rest.uniprot.org/uniprotkb/P19397.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P19397/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P19397"}},"corpus_meta":[{"pmid":"17438075","id":"PMC_17438075","title":"In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17438075","citation_count":265,"is_preprint":false},{"pmid":"8757325","id":"PMC_8757325","title":"Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29).","date":"1996","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8757325","citation_count":200,"is_preprint":false},{"pmid":"8816400","id":"PMC_8816400","title":"Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.","date":"1996","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8816400","citation_count":177,"is_preprint":false},{"pmid":"8119731","id":"PMC_8119731","title":"Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins.","date":"1994","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/8119731","citation_count":165,"is_preprint":false},{"pmid":"9514697","id":"PMC_9514697","title":"Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity.","date":"1997","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9514697","citation_count":127,"is_preprint":false},{"pmid":"1401919","id":"PMC_1401919","title":"C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63.","date":"1992","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1401919","citation_count":115,"is_preprint":false},{"pmid":"1700763","id":"PMC_1700763","title":"The human leucocyte surface antigen CD53 is a protein structurally similar to the CD37 and MRC OX-44 antigens.","date":"1990","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/1700763","citation_count":73,"is_preprint":false},{"pmid":"2258620","id":"PMC_2258620","title":"Identification and analysis of cDNA clones encoding CD53. A pan-leukocyte antigen related to membrane transport proteins.","date":"1990","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2258620","citation_count":69,"is_preprint":false},{"pmid":"8335905","id":"PMC_8335905","title":"CD53, a protein with four membrane-spanning domains, mediates signal transduction in human monocytes and B cells.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8335905","citation_count":68,"is_preprint":false},{"pmid":"16506060","id":"PMC_16506060","title":"The effects of intensive, moderate and downhill treadmill running on human blood lymphocytes expressing the adhesion/activation molecules CD54 (ICAM-1), CD18 (beta2 integrin) and CD53.","date":"2006","source":"European journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16506060","citation_count":67,"is_preprint":false},{"pmid":"32440787","id":"PMC_32440787","title":"Tetraspanin CD53: an overlooked regulator of immune cell function.","date":"2020","source":"Medical microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32440787","citation_count":51,"is_preprint":false},{"pmid":"7511680","id":"PMC_7511680","title":"Induction of nitric oxide release by MRC OX-44 (anti-CD53) through a protein kinase C-dependent pathway in rat macrophages.","date":"1994","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7511680","citation_count":51,"is_preprint":false},{"pmid":"12606948","id":"PMC_12606948","title":"Apoptosis protection and survival signal by the CD53 tetraspanin antigen.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12606948","citation_count":49,"is_preprint":false},{"pmid":"9067662","id":"PMC_9067662","title":"Recurrent infectious diseases in human CD53 deficiency.","date":"1997","source":"Clinical and diagnostic laboratory immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9067662","citation_count":48,"is_preprint":false},{"pmid":"7621882","id":"PMC_7621882","title":"Association of the transmembrane 4 superfamily molecule CD53 with a tyrosine phosphatase activity.","date":"1995","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7621882","citation_count":44,"is_preprint":false},{"pmid":"23570947","id":"PMC_23570947","title":"Characterization of tetraspanins CD9, CD53, CD63, and CD81 in monocytes and macrophages in HIV-1 infection.","date":"2013","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/23570947","citation_count":43,"is_preprint":false},{"pmid":"28878339","id":"PMC_28878339","title":"Pathogen lineage-based genome-wide association study identified CD53 as susceptible locus in tuberculosis.","date":"2017","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28878339","citation_count":43,"is_preprint":false},{"pmid":"9470900","id":"PMC_9470900","title":"Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin.","date":"1997","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/9470900","citation_count":39,"is_preprint":false},{"pmid":"7678222","id":"PMC_7678222","title":"Epitope mapping of anti-rat CD53 monoclonal antibodies. Implications for the membrane orientation of the Transmembrane 4 Superfamily.","date":"1993","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7678222","citation_count":38,"is_preprint":false},{"pmid":"8452817","id":"PMC_8452817","title":"Gene structure, chromosomal localization, and protein sequence of mouse CD53 (Cd53): evidence that the transmembrane 4 superfamily arose by gene duplication.","date":"1993","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8452817","citation_count":38,"is_preprint":false},{"pmid":"10733097","id":"PMC_10733097","title":"Increased expression of the tetraspanins CD53 and CD63 on apoptotic human neutrophils.","date":"2000","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/10733097","citation_count":34,"is_preprint":false},{"pmid":"32428859","id":"PMC_32428859","title":"Tetraspanin CD53 Promotes Lymphocyte Recirculation by Stabilizing L-Selectin Surface Expression.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/32428859","citation_count":31,"is_preprint":false},{"pmid":"7963560","id":"PMC_7963560","title":"Cross-linking of CD53 promotes activation of resting human B lymphocytes.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7963560","citation_count":31,"is_preprint":false},{"pmid":"24832104","id":"PMC_24832104","title":"The tetraspanin CD53 modulates responses from activating NK cell receptors, promoting LFA-1 activation and dampening NK cell effector functions.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24832104","citation_count":30,"is_preprint":false},{"pmid":"9241532","id":"PMC_9241532","title":"Anti-CD53 monoclonal antibody induced LFA-1/ICAM-1-dependent and -independent lymphocyte homotypic cell aggregation.","date":"1997","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/9241532","citation_count":26,"is_preprint":false},{"pmid":"9225004","id":"PMC_9225004","title":"Ligation of CD53/OX44, a tetraspan antigen, induces homotypic adhesion mediated by specific cell-cell interactions.","date":"1997","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9225004","citation_count":26,"is_preprint":false},{"pmid":"31748347","id":"PMC_31748347","title":"The Tetraspanin CD53 Regulates Early B Cell Development by Promoting IL-7R Signaling.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31748347","citation_count":25,"is_preprint":false},{"pmid":"7545113","id":"PMC_7545113","title":"Characterization of mouse CD53: epitope mapping, cellular distribution and induction by T cell receptor engagement during repertoire selection.","date":"1995","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7545113","citation_count":25,"is_preprint":false},{"pmid":"35767951","id":"PMC_35767951","title":"Tetraspanin CD53 controls T cell immunity through regulation of CD45RO stability, mobility, and function.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35767951","citation_count":24,"is_preprint":false},{"pmid":"33519905","id":"PMC_33519905","title":"Identifying RBM47, HCK, CD53, TYROBP, and HAVCR2 as Hub Genes in Advanced Atherosclerotic Plaques by Network-Based Analysis and Validation.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33519905","citation_count":24,"is_preprint":false},{"pmid":"11867561","id":"PMC_11867561","title":"CD53, a thymocyte selection marker whose induction requires a lower affinity TCR-MHC interaction than CD69, but is up-regulated with slower kinetics.","date":"2002","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11867561","citation_count":24,"is_preprint":false},{"pmid":"20407468","id":"PMC_20407468","title":"A genome-wide linkage scan reveals CD53 as an important regulator of innate TNF-alpha levels.","date":"2010","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/20407468","citation_count":23,"is_preprint":false},{"pmid":"9620662","id":"PMC_9620662","title":"Physiological activation of human neutrophils down-regulates CD53 cell surface antigen.","date":"1998","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/9620662","citation_count":22,"is_preprint":false},{"pmid":"23313165","id":"PMC_23313165","title":"CD53, a suppressor of inflammatory cytokine production, is associated with population asthma risk via the functional promoter polymorphism -1560 C>T.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23313165","citation_count":21,"is_preprint":false},{"pmid":"15055538","id":"PMC_15055538","title":"LPS-induced CD53 expression: a protection mechanism against oxidative and radiation stress.","date":"2004","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/15055538","citation_count":20,"is_preprint":false},{"pmid":"11846804","id":"PMC_11846804","title":"Transient activation of the c-Jun N-terminal kinase (JNK) activity by ligation of the tetraspan CD53 antigen in different cell types.","date":"2002","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11846804","citation_count":18,"is_preprint":false},{"pmid":"35201443","id":"PMC_35201443","title":"New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAP.","date":"2021","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35201443","citation_count":18,"is_preprint":false},{"pmid":"36581203","id":"PMC_36581203","title":"The tetraspanin transmembrane protein CD53 mediates dyslipidemia and integrates inflammatory and metabolic signaling in hepatocytes.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36581203","citation_count":15,"is_preprint":false},{"pmid":"8404042","id":"PMC_8404042","title":"Chromosomal localization of the Ox-44 (CD53) leukocyte antigen gene in man and rodents.","date":"1993","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8404042","citation_count":15,"is_preprint":false},{"pmid":"8436422","id":"PMC_8436422","title":"The genes for CD37, CD53, and R2, all members of a novel gene family, are located on different chromosomes.","date":"1993","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/8436422","citation_count":15,"is_preprint":false},{"pmid":"32532837","id":"PMC_32532837","title":"Leukocyte Tetraspanin CD53 Restrains α3 Integrin Mobilization and Facilitates Cytoskeletal Remodeling and Transmigration in Mice.","date":"2020","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/32532837","citation_count":12,"is_preprint":false},{"pmid":"8319976","id":"PMC_8319976","title":"Genomic structure of the human CD53 gene.","date":"1993","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/8319976","citation_count":12,"is_preprint":false},{"pmid":"7533082","id":"PMC_7533082","title":"Expression of cell interaction molecules by immature rat thymocytes during passage through the CD4+8+ compartment: developmental regulation and induction by T cell receptor engagement of CD2, CD5, CD28, CD11a, CD44 and CD53.","date":"1995","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7533082","citation_count":12,"is_preprint":false},{"pmid":"36542833","id":"PMC_36542833","title":"The tetraspanin CD53 protects stressed hematopoietic stem cells via promotion of DREAM complex-mediated quiescence.","date":"2023","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/36542833","citation_count":11,"is_preprint":false},{"pmid":"30506122","id":"PMC_30506122","title":"Association between CD53 genetic polymorphisms and tuberculosis cases.","date":"2018","source":"Genes & genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30506122","citation_count":10,"is_preprint":false},{"pmid":"17429843","id":"PMC_17429843","title":"The CD53 and CEACAM-1 genes are genetic targets for early B cell factor.","date":"2007","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17429843","citation_count":8,"is_preprint":false},{"pmid":"8612282","id":"PMC_8612282","title":"CD53 antigen and epidermal growth factor induce similar changes in the pattern of phorbol ester binding in a B cell lymphoma.","date":"1996","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8612282","citation_count":8,"is_preprint":false},{"pmid":"38031400","id":"PMC_38031400","title":"N-Glycosylation-dependent regulation of immune-specific tetraspanins CD37 and CD53.","date":"2023","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/38031400","citation_count":7,"is_preprint":false},{"pmid":"26631805","id":"PMC_26631805","title":"Down-regulation of CD53 expression in Epinephelus coioides under LPS, poly (I:C), and cytokine stimulation.","date":"2015","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26631805","citation_count":7,"is_preprint":false},{"pmid":"12631118","id":"PMC_12631118","title":"Induction of DNA synthesis by ligation of the CD53 tetraspanin antigen in primary cultures of mesangial cells.","date":"2003","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/12631118","citation_count":6,"is_preprint":false},{"pmid":"34514627","id":"PMC_34514627","title":"Tetraspanin CD53 modulates lymphocyte trafficking but not systemic autoimmunity in Lyn-deficient mice.","date":"2021","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/34514627","citation_count":5,"is_preprint":false},{"pmid":"40098997","id":"PMC_40098997","title":"Inhibition of CD53 Reduces the Formation of ROS-Induced Neutrophil Extracellular Traps and Protects Against Inflammatory Injury in Acute Pancreatitis.","date":"2025","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/40098997","citation_count":3,"is_preprint":false},{"pmid":"38296007","id":"PMC_38296007","title":"Tetraspanin CD53 regulates peripheral blood leucocytes vitality and pathogen infection in turbot (Scophthalmus maximus).","date":"2024","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38296007","citation_count":2,"is_preprint":false},{"pmid":"40624623","id":"PMC_40624623","title":"CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implications.","date":"2025","source":"BMC nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/40624623","citation_count":1,"is_preprint":false},{"pmid":"41921791","id":"PMC_41921791","title":"Pathogenic implication of the CD53 tetraspanin in immune and cancer cells.","date":"2026","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/41921791","citation_count":0,"is_preprint":false},{"pmid":"39159818","id":"PMC_39159818","title":"The conformation of tetraspanins CD53 and CD81 differentially affects their nanoscale organization and interaction with their partners.","date":"2024","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39159818","citation_count":0,"is_preprint":false},{"pmid":"38363205","id":"PMC_38363205","title":"Cutting Edge: The Tetraspanin CD53 Promotes CXCR4 Signaling and Bone Marrow Homing in B Cells.","date":"2024","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/38363205","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.02.05.636492","title":"HSCs and Tregs cooperate to preserve extramedullary hematopoiesis under chronic inflammation","date":"2025-02-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.05.636492","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.21.619446","title":"A TEMPORAL MODEL OF TUMOR-IMMUNE DYNAMICS IN HIGH GRADE SEROUS OVARIAN CANCER","date":"2024-10-24","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.21.619446","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.10.617576","title":"Mapping the Spatial Proteome of Leukemia Cells Undergoing Fludarabine Treatment","date":"2024-10-11","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.10.617576","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":28130,"output_tokens":7099,"usd":0.095437},"stage2":{"model":"claude-opus-4-6","input_tokens":10928,"output_tokens":3966,"usd":0.230685},"total_usd":0.326122,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"CD53 is a 219-amino acid type III integral membrane protein with four transmembrane domains and N-glycosylation sites, constituting the structural basis of the tetraspanin family; it is the human homologue of rat OX-44.\",\n      \"method\": \"cDNA cloning, sequence analysis, immunoprecipitation of transfected cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original molecular characterization by two independent groups using cDNA cloning and expression\",\n      \"pmids\": [\"2258620\", \"1700763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Cross-linking of CD53 on human B cells, monocytes, and granulocytes triggers cytoplasmic calcium fluxes and activates the monocyte oxidative burst; signaling is largely independent of protein kinase C but sensitive to high-dose staurosporine and dependent on tyrosine kinases rather than GTP-binding proteins.\",\n      \"method\": \"Cross-linking of cell-bound F(ab')2 anti-CD53 mAb; calcium flux assay; oxidative burst assay; pharmacological inhibitors (staurosporine, ADP-ribosylating toxins)\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays with defined pharmacological dissection\",\n      \"pmids\": [\"8335905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The major extracellular (hydrophilic) loop of CD53 contains epitopes recognized by anti-CD53 mAbs (OX-44, 2D1, 6E2, 7D2), and these epitopes are sensitive to reduction, demonstrating the importance of disulfide bonding in the correct folding of the CD53 extracellular domain and directly confirming the four-transmembrane topology.\",\n      \"method\": \"Epitope mapping using GST-fusion chimeric proteins and anti-rat CD53 mAbs; reduction sensitivity assays\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct molecular epitope mapping with mutagenesis-equivalent chimeric proteins\",\n      \"pmids\": [\"7678222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CD53 (together with CD37, TAPA-1/CD81, and R2/C33) co-precipitates with MHC class II (DR) glycoproteins from B cell lysates in mild detergent, forming large multicomponent complexes on the B cell surface.\",\n      \"method\": \"Co-immunoprecipitation and preclearing experiments from human B-cell line and tonsillar B cell lysates\",\n      \"journal\": \"Immunogenetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-immunoprecipitation replicated across cell types\",\n      \"pmids\": [\"8119731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Activation of CD53 in rat macrophages by antibody cross-linking increases inositol phosphates, diacylglycerol, and intracellular Ca2+ (insensitive to pertussis/cholera toxins), leads to protein kinase C translocation to the membrane, and induces expression of inducible nitric oxide synthase (iNOS) resulting in nitric oxide release in a PKC- and protein synthesis-dependent manner.\",\n      \"method\": \"Antibody cross-linking; inositol phosphate and diacylglycerol measurement; Ca2+ mobilization; PKC translocation assay; NO measurement; iNOS expression analysis; pharmacological inhibitors\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biochemical assays defining a complete signaling pathway\",\n      \"pmids\": [\"7511680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Cross-linking of CD53 on resting human B lymphocytes promotes their entry into G1 phase (increased CD69, cell volume, RNA synthesis, c-myc levels), and in combination with cytokines (IL-2, IL-4) induces DNA synthesis and immunoglobulin production.\",\n      \"method\": \"Anti-CD53 mAb cross-linking; flow cytometry; RNA synthesis measurement; c-myc immunoblot; [3H]thymidine incorporation; Ig ELISA\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal readouts of B cell activation with defined costimulatory context\",\n      \"pmids\": [\"7963560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Immune complexes of rat CD53 contain tyrosine phosphatase activity capable of dephosphorylating Lck in vitro; the phosphatase is distinct from CD45 and is inhibited by tyrosine phosphatase inhibitors. CD63 similarly co-precipitates a phosphatase.\",\n      \"method\": \"Immunoprecipitation from lymph node and thymoma lysates; in vitro phosphatase activity assay on phospho-Lck and synthetic substrate; depletion experiments; phosphatase inhibitor treatment\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro enzyme activity assay, but identity of the phosphatase not established\",\n      \"pmids\": [\"7621882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CD53, CD82, CD63, and CD81 specifically associate with integrin α4β1 (VLA-4/CD49d/CD29) on hematopoietic cell lines, as shown by reciprocal co-immunoprecipitation; the association is independent of the α4 cytoplasmic domain and divalent cations but is lost in two α4 adhesion-deficient mutants (D346E and D408E).\",\n      \"method\": \"Reciprocal co-immunoprecipitation; confocal microscopy; mutant integrin transfectants; divalent cation chelation\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with mutational dissection replicated across multiple cell lines\",\n      \"pmids\": [\"8757325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CD53, CD81, and CD82 are in close proximity (2–10 nm) to MHC class II (DR, DQ), MHC class I, and CD20 on B cell surfaces, forming supramolecular complexes; FRET analysis suggests all these molecules participate in a single multi-component assembly.\",\n      \"method\": \"Flow cytometric FRET (fluorescence energy transfer) with fluorescently labeled mAbs\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — biophysical FRET approach with quantitative distance constraints\",\n      \"pmids\": [\"8816400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CD53 ligation on lymphoma B cells (rat IR938F) induces homotypic adhesion that requires divalent cations (Ca2+, Mg2+), de novo protein synthesis, and is mediated by tyrosine kinase (genistein/piceatannol-sensitive), PI3K (wortmannin-sensitive), and PKC (H7/bisindolylmaleimide-sensitive) signaling pathways, but is LFA-1-independent; electron microscopy reveals localized membrane contact zones.\",\n      \"method\": \"Anti-CD53 mAb cross-linking; cell aggregation assay; pharmacological inhibitors (genistein, piceatannol, wortmannin, H7, bisindolylmaleimide, cycloheximide, actinomycin D, EGTA/EDTA); immunoelectron microscopy\",\n      \"journal\": \"Cellular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple pathway inhibitors with orthogonal structural readout\",\n      \"pmids\": [\"9225004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Anti-CD53 mAb induces homotypic aggregation of lymphoid cell lines via both LFA-1/ICAM-1-dependent and -independent pathways; aggregation is energy-dependent and partially blocked by anti-LFA-1 or anti-ICAM-1, but not by anti-CD44 or anti-CD49d mAbs.\",\n      \"method\": \"Anti-CD53 mAb cross-linking; blocking mAb experiments; cell aggregation assay including a LAD patient B cell line lacking LFA-1\",\n      \"journal\": \"Immunobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — use of LAD patient cells as genetic control for LFA-1 independence\",\n      \"pmids\": [\"9241532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Anti-CD53 mAb (like anti-CD9, anti-CD81, anti-CD82 mAbs) delivers a costimulatory signal for CD3-mediated T cell activation and inhibits migration of megakaryocytic and pre-B cell lines, consistent with CD53 participation in a tetraspan network.\",\n      \"method\": \"mAb cross-linking; T cell costimulation assay; homotypic aggregation and migration inhibition assays in HEL and NALM-6 cell lines\",\n      \"journal\": \"Cellular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — parallel comparison of four tetraspanins in same assay\",\n      \"pmids\": [\"9514697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Physiological neutrophil activators (TNFα, PAF, fMLP, PMA, ionomycin) cause down-regulation of CD53 from the neutrophil cell surface via a proteolytic mechanism (inhibited by PMSFP), without changes in CD53 transcript levels.\",\n      \"method\": \"Flow cytometry; immunoblotting; pharmacological inhibition (PMSF); Northern/RT analysis\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple activators and orthogonal protein/mRNA analysis\",\n      \"pmids\": [\"9620662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Ligation of CD53 (rat or human) induces a transient 3–4-fold activation of JNK that peaks at 3–5 min in B-cell lymphoma and T-cell lymphoma lines, and in a renal carcinoma line transiently transfected with human CD53; this JNK activation is independent of Vav and sufficient to stimulate Jun-dependent transcription.\",\n      \"method\": \"Anti-CD53 mAb cross-linking; in vitro JNK kinase assay (endogenous and exogenous); Jun-dependent transcriptional reporter; Vav co-stimulation assay\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — kinase activity assay across multiple cell lines with genetic dissection from Vav\",\n      \"pmids\": [\"11846804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CD53 ligation on tumor B and T cells (IR938F, Jurkat) reduces apoptosis induced by serum deprivation, decreases caspase activation and DNA fragmentation, increases Bcl-xL and decreases Bax, and activates AKT (phosphorylation at Ser473).\",\n      \"method\": \"Anti-CD53 mAb cross-linking; PARP cleavage assay; DNA fragmentation assay; Bcl-xL/Bax immunoblot; AKT phosphorylation immunoblot\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal apoptosis readouts with defined AKT mechanistic link\",\n      \"pmids\": [\"12606948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CD53 ligation in rat mesangial cells triggers DNA synthesis via ERK1/ERK2 activation (blocked by PD98059/MEK inhibitor), but not through PI3K, PKC, or calcium channel pathways; CD53 is expressed in mesangial cells in vivo.\",\n      \"method\": \"Anti-CD53 mAb cross-linking; [3H]thymidine incorporation; ERK phosphorylation by immunoblot; pharmacological inhibitors (PD98059, wortmannin, PKC inhibitors, thapsigargin, verapamil); flow cytometry for apoptosis\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway dissection with specific MEK inhibitor and multiple negative controls\",\n      \"pmids\": [\"12631118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CD53 overexpression in macrophages increases intracellular GSH, lowers peroxide levels, and confers resistance to H2O2 and UVB irradiation; antisense CD53 has the opposite effects; CD53 is induced by LPS and nitric oxide (SNAP) in macrophages.\",\n      \"method\": \"Stable sense and antisense CD53 transfection; GSH measurement; peroxide assay; H2O2 and UVB cell viability assays; Northern blot; microarray\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with multiple biochemical readouts\",\n      \"pmids\": [\"15055538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In macrophages, HIV-1 buds into an intracellular plasma membrane domain containing tetraspanins CD81, CD9, and CD53 (not classic endosomes); this compartment is connected to the cell surface (accessible to extracellular tracers at 4°C) and lacks endosome markers including CD63.\",\n      \"method\": \"Immunofluorescence microscopy; immunoelectron microscopy; horseradish peroxidase and ruthenium red tracer accessibility assays; marker co-localization\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple imaging modalities with direct biochemical accessibility assay\",\n      \"pmids\": [\"17438075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CD53 gene expression is directly regulated by the transcription factor EBF1; functional EBF1 binding sites are present in the CD53 promoter and EBF1 expression drives CD53 transcription in transient transfection assays.\",\n      \"method\": \"Retroviral EBF1 transduction of BaF/3 cells; microarray; promoter 5' end mapping; transient transfection transcriptional assays\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter functional analysis with gain-of-function in hematopoietic progenitor cells\",\n      \"pmids\": [\"17429843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CD53 knockdown by siRNA in THP-1 monocytic cells stimulated with house dust mite significantly increases production of inflammatory cytokines and NFκB activity, demonstrating that CD53 suppresses over-activation of inflammatory cytokine responses.\",\n      \"method\": \"siRNA knockdown; cytokine ELISA; NFκB activity assay\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNAi loss-of-function with signaling pathway readout\",\n      \"pmids\": [\"23313165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CD53 ligation on rat NK cells reduces degranulation and IFNγ responses to activating NK receptors (Ly49s3, NKR-P1A, NKp46), induces activation of the β2 integrin LFA-1, promotes homotypic NK cell adhesion, and enhances NK cell proliferation in response to IL-2.\",\n      \"method\": \"Anti-CD53 mAb cross-linking; degranulation assay; redirected killing assay; IFNγ ELISA; LFA-1 activation flow cytometry; proliferation assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays in primary NK cells\",\n      \"pmids\": [\"24832104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CD53 physically interacts with IL-7Rα and promotes IL-7 signaling (PI3K and JAK/STAT pathways) in developing B cells; loss of CD53 reduces IL-7Rα surface expression, increases apoptosis in pro-B cells, and blocks the pro-B to pre-B transition.\",\n      \"method\": \"Co-immunoprecipitation; proximity ligation assay; flow cytometry for IL-7Rα; phospho-flow for PI3K and JAK/STAT; apoptosis assays; mixed bone marrow chimeras\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — physical interaction confirmed by two methods (Co-IP + PLA) with cell-autonomous KO phenotype\",\n      \"pmids\": [\"31748347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD53 stabilizes L-selectin surface expression on B and T cells, restrains L-selectin shedding via both ADAM17-dependent and ADAM17-independent mechanisms, and is required for efficient lymphocyte homing to lymph nodes; Cd53−/− mice have markedly smaller lymph nodes due to reduced B and T cell homing.\",\n      \"method\": \"Cd53−/− mouse analysis; flow cytometry for L-selectin; adoptive transfer homing assays; ADAM17 inhibitor experiments; in vivo lymph node cellularity\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with multiple orthogonal assays and defined molecular mechanism (L-selectin/ADAM17)\",\n      \"pmids\": [\"32428859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD53 restrains α3 integrin mobilization in neutrophils, promotes cytoskeletal remodeling and transendothelial migration; Cd53−/− neutrophils show defective transmigration across endothelium in response to TNF, CXCL1, and CCL2, and near-complete absence of L-selectin.\",\n      \"method\": \"Cd53−/− mouse; intravital microscopy; peritoneal inflammation model; flow cytometry for adhesion molecules and integrins; cytoskeletal remodeling assays; serum-induced arthritis model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — intravital imaging plus multiple in vivo inflammatory models with defined molecular correlates\",\n      \"pmids\": [\"32532837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CD53 interacts with CD45 (identified by unbiased mass spectrometry) and is required for CD45RO isoform expression, CD45 membrane stability and mobility, and optimal CD45 phosphatase activity, leading to Lck activation; Cd53−/− T cells show proliferation defects and impaired tumor rejection.\",\n      \"method\": \"Unbiased mass spectrometry; proximity ligation assay; FRAP (fluorescence recovery after photobleaching); phosphatase activity assay; Lck activation immunoblot; in vivo tumor rejection model; IFNγ ELISPOT\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — unbiased proteomics, biophysical membrane analysis, enzymatic activity, and in vivo functional validation\",\n      \"pmids\": [\"35767951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CD53 integrates inflammatory and metabolic signals in hepatocytes; CD53 deletion blocks Western diet-induced dyslipidemia, hepatic inflammatory gene expression, and triglyceride accumulation; CD53 deletion attenuates TNFα- and fatty acid+LPS-induced cytokine expression in isolated hepatocytes.\",\n      \"method\": \"Germline CD53 KO mice; Western diet feeding; NASH diet model; primary hepatocyte isolation; cytokine gene expression; triglyceride assay; glucose transporter 8 deletion and trehalose treatment as comparators\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse plus isolated hepatocyte experiments with multiple dietary/inflammatory models\",\n      \"pmids\": [\"36581203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CD53 interacts with DREAM complex-associated proteins, specifically promoting the interaction between Rbl2/p130 and its phosphatase PP2A, stabilizing p130 for DREAM complex assembly; this promotes HSC quiescence following inflammatory stress, and loss of CD53 leads to prolonged cycling and reduced HSC function.\",\n      \"method\": \"Proximity labeling proteomics; confocal fluorescence microscopy; DREAM complex co-immunoprecipitation; PP2A-p130 interaction assay; Cd53−/− HSC cell cycle analysis; 5-FU stress model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — proximity labeling plus co-IP for molecular mechanism, with in vivo KO validation\",\n      \"pmids\": [\"36542833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Glycosylation of CD53 inhibits its interaction with partner proteins CD45, CD20, and CD37; abrogation of CD53 glycosylation does not affect surface expression but increases interaction with partners. CD37 glycosylation is required for its surface expression, while CD53 glycosylation controls partner protein interaction capacity.\",\n      \"method\": \"Glycosylation mutant generation; surface expression flow cytometry; single-molecule dSTORM super-resolution microscopy; co-immunoprecipitation\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with super-resolution imaging and Co-IP\",\n      \"pmids\": [\"38031400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CD53 physically interacts with CXCR4 (confirmed by proximity ligation assay) and promotes CXCL12-induced CXCR4 signaling and receptor internalization; Cd53−/− B cells show reduced CXCL12 migration in vitro and impaired bone marrow homing in vivo.\",\n      \"method\": \"Proximity ligation assay; in vitro migration assay; CXCR4 signaling (phospho-flow); CXCR4 internalization assay; in vivo homing assay in Cd53−/− mice\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — physical interaction by PLA combined with functional receptor assays and in vivo validation\",\n      \"pmids\": [\"38363205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The 'closed' conformational mutant of CD53 (F44E) shows increased clustering in nanodomains and greater interaction with its partner CD45 compared to wild-type CD53; absence of CD53 increases CD45 clustering tendency, indicating CD53 conformation regulates its nanoscale membrane organization and partner interactions.\",\n      \"method\": \"Conformational mutant generation (F44E); super-resolution dSTORM microscopy; co-immunoprecipitation; CD53 KO B cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — structure-function mutagenesis with super-resolution imaging\",\n      \"pmids\": [\"39159818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CD53 promotes ROS-induced neutrophil extracellular trap (NET) formation via modulation of the PI3K/AKT pathway; anti-CD53 neutralizing antibody inhibits NET formation in vitro and reduces inflammatory injury in a caerulein-induced acute pancreatitis mouse model.\",\n      \"method\": \"PMA-induced in vitro NET model; anti-CD53 neutralizing antibody; PI3K/AKT pathway analysis; caerulein AP mouse model; NET quantification in tissues\",\n      \"journal\": \"Journal of inflammation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo loss-of-function with defined signaling pathway\",\n      \"pmids\": [\"40098997\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD53 is a leukocyte-restricted four-transmembrane tetraspanin that organizes plasma membrane microdomains and acts as a signaling scaffold: it physically associates with MHC class II, integrins (α4β1, α3), L-selectin, IL-7Rα, CXCR4, CD45, and other tetraspanins to regulate lymphocyte homing (via L-selectin stabilization and ADAM17 restraint), early B cell development (via IL-7R/PI3K/JAK-STAT signaling), T cell activation (via CD45RO stability and Lck activation), NK cell effector/proliferative balance (via LFA-1 activation), HSC quiescence (via PP2A–p130/DREAM complex), and myeloid cell transmigration and inflammatory cytokine responses; its ligation triggers calcium flux, PKC translocation, iNOS/NO production, AKT-mediated survival, JNK activation, and ERK-dependent proliferation, with glycosylation and conformational state providing additional layers of regulation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CD53 is a leukocyte-enriched tetraspanin that organizes plasma membrane signaling platforms to regulate lymphocyte trafficking, activation, and innate immune cell inflammatory responses. It physically associates with MHC class II, integrins (α4β1, α3), L-selectin, IL-7Rα, CXCR4, and CD45, stabilizing these partners at the cell surface and modulating their signaling output: CD53 promotes IL-7R/PI3K/JAK-STAT signaling required for the pro-B to pre-B transition [PMID:31748347], stabilizes L-selectin to enable lymphocyte homing to lymph nodes [PMID:32428859], sustains CD45RO isoform expression and Lck activation for T cell proliferation and anti-tumor immunity [PMID:35767951], and facilitates CXCR4-driven B cell migration and bone marrow homing [PMID:38363205]. Beyond adaptive immunity, CD53 ligation activates calcium flux, PKC, JNK, ERK, and AKT pathways in myeloid and mesangial cells [PMID:7511680, PMID:12606948, PMID:12631118], restrains inflammatory cytokine production via NF-κB suppression [PMID:23313165], promotes neutrophil transendothelial migration and NET formation [PMID:32532837, PMID:40098997], and maintains hematopoietic stem cell quiescence by scaffolding the PP2A–p130/DREAM complex [PMID:36542833].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Establishing CD53 as a founding tetraspanin resolved its four-transmembrane topology and N-glycosylation, providing the structural framework for understanding how it scaffolds membrane complexes.\",\n      \"evidence\": \"cDNA cloning and sequence analysis of human CD53 and its rat homologue OX-44\",\n      \"pmids\": [\"2258620\", \"1700763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure of CD53\", \"Stoichiometry of CD53 in membrane complexes unknown\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Demonstrating that CD53 cross-linking triggers calcium flux and tyrosine kinase-dependent signaling established CD53 as an active signaling molecule rather than a passive structural component.\",\n      \"evidence\": \"Anti-CD53 F(ab')2 cross-linking on B cells, monocytes, granulocytes with calcium flux and pharmacological inhibitors; disulfide-dependent epitope mapping on extracellular loop\",\n      \"pmids\": [\"8335905\", \"7678222\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the proximal tyrosine kinase not determined\", \"Physiological ligand unknown\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Discovery that CD53 co-precipitates with MHC class II and other tetraspanins on B cells, and that its ligation induces PKC translocation, iNOS/NO production in macrophages, and B cell activation (G1 entry, Ig secretion), positioned CD53 as a central organizer of immune cell surface signaling platforms.\",\n      \"evidence\": \"Co-immunoprecipitation from B cell lysates; anti-CD53 cross-linking with PKC, iNOS, calcium, and B cell activation readouts\",\n      \"pmids\": [\"8119731\", \"7511680\", \"7963560\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD53 directly contacts MHC class II or requires bridging tetraspanins not resolved\", \"Relative contribution of PKC versus tyrosine kinase arms to macrophage NO production unclear\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Reciprocal co-immunoprecipitation with integrin α4β1 and FRET-based proximity mapping with MHC class I/II and CD20 established that CD53 participates in multi-component supramolecular assemblies organized at nanometer scale on leukocyte surfaces.\",\n      \"evidence\": \"Reciprocal co-IP with mutant integrin dissection; flow cytometric FRET on B cells\",\n      \"pmids\": [\"8757325\", \"8816400\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether complexes are pre-formed or activation-dependent not fully resolved\", \"Contribution of lipid composition to complex stability unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Pathway dissection of CD53-induced homotypic adhesion revealed that CD53 engages tyrosine kinase, PI3K, and PKC cascades to drive adhesion through both LFA-1-dependent and -independent routes, indicating CD53 can activate multiple downstream effector modules simultaneously.\",\n      \"evidence\": \"Anti-CD53 cross-linking with pharmacological inhibitors (genistein, wortmannin, PKC inhibitors); LAD patient cells lacking LFA-1; immunoelectron microscopy\",\n      \"pmids\": [\"9225004\", \"9241532\", \"9514697\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"LFA-1-independent adhesion molecule not identified\", \"Whether CD53-induced adhesion occurs via inside-out integrin signaling not directly tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of JNK as a rapid downstream effector of CD53 ligation, independent of Vav, extended the signaling repertoire beyond calcium/PKC and linked CD53 to Jun-dependent transcriptional programs.\",\n      \"evidence\": \"In vitro JNK kinase assay after anti-CD53 cross-linking in B and T cell lymphoma lines; Jun-dependent reporter\",\n      \"pmids\": [\"11846804\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream kinase coupling CD53 to JNK not identified\", \"In vivo relevance of CD53-JNK axis not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Connecting CD53 to AKT-mediated survival signaling (Bcl-xL upregulation, Bax downregulation) and ERK-dependent proliferation in mesangial cells broadened CD53 function beyond immune activation to include cytoprotection and mitogenesis.\",\n      \"evidence\": \"Anti-CD53 cross-linking with AKT phosphorylation, apoptosis readouts in lymphoma cells; ERK phosphorylation and thymidine incorporation with MEK inhibitor in mesangial cells\",\n      \"pmids\": [\"12606948\", \"12631118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CD53 selectively activates AKT versus ERK in different cell types not explained\", \"Mesangial cell findings lack genetic loss-of-function validation\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Localization of CD53 to macrophage intracellular plasma membrane compartments used by HIV-1 for budding revealed a role for CD53-enriched domains in pathogen biology, while identification of EBF1 as a transcriptional regulator placed CD53 expression under B-lineage developmental control.\",\n      \"evidence\": \"Immunoelectron microscopy and tracer accessibility in macrophages; EBF1 retroviral transduction and promoter analysis\",\n      \"pmids\": [\"17438075\", \"17429843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD53 actively facilitates or restricts HIV budding not determined\", \"Whether other transcription factors cooperate with EBF1 for CD53 induction not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Using Cd53-knockout mice and proximity ligation, the demonstration that CD53 physically stabilizes IL-7Rα to promote PI3K and JAK-STAT signaling provided the first in vivo genetic evidence that CD53 is essential for a specific developmental checkpoint — the pro-B to pre-B transition.\",\n      \"evidence\": \"Co-IP and PLA for CD53–IL-7Rα; phospho-flow; apoptosis assays; mixed bone marrow chimeras in Cd53−/− mice\",\n      \"pmids\": [\"31748347\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD53 regulates IL-7Rα recycling or solely surface retention not distinguished\", \"Structural basis of CD53–IL-7Rα interaction unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Cd53−/− mouse studies revealed that CD53 stabilizes L-selectin by restraining ADAM17-mediated shedding and modulates α3 integrin in neutrophils, establishing CD53 as a master regulator of leukocyte trafficking to lymph nodes and inflammatory sites.\",\n      \"evidence\": \"Cd53−/− adoptive transfer homing assays; ADAM17 inhibitor experiments; intravital microscopy; peritoneal inflammation and arthritis models\",\n      \"pmids\": [\"32428859\", \"32532837\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface between CD53 and L-selectin or ADAM17 not mapped\", \"Whether CD53 physically sequesters ADAM17 or acts indirectly not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Unbiased mass spectrometry identified CD45 as a key CD53 partner, and functional studies showed CD53 is required for CD45RO isoform expression, CD45 membrane mobility, and Lck activation — linking CD53 to the core TCR proximal signaling apparatus and explaining impaired anti-tumor T cell responses in Cd53−/− mice.\",\n      \"evidence\": \"Mass spectrometry; PLA; FRAP; phosphatase activity assay; in vivo tumor rejection in Cd53−/− mice\",\n      \"pmids\": [\"35767951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD53 influences CD45 alternative splicing or post-translational processing not distinguished\", \"Mechanism by which CD53 controls CD45 membrane dynamics not elucidated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extension of CD53 function beyond hematopoietic cells: CD53 deletion in hepatocytes attenuated Western diet-induced dyslipidemia and inflammatory gene expression, indicating CD53 integrates inflammatory and metabolic signals in non-immune cells.\",\n      \"evidence\": \"Germline CD53 KO mice on Western/NASH diets; primary hepatocyte cytokine and triglyceride assays\",\n      \"pmids\": [\"36581203\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type-specific conditional KO not used; hepatocyte-autonomous role versus secondary immune effects not fully separated\", \"Hepatocyte signaling partners of CD53 not identified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery that CD53 scaffolds the PP2A–p130 interaction to stabilize the DREAM complex and promote HSC quiescence after inflammatory stress revealed a novel non-canonical tetraspanin function in stem cell biology.\",\n      \"evidence\": \"Proximity labeling proteomics; PP2A–p130 co-IP; Cd53−/− HSC cell cycle analysis after 5-FU stress\",\n      \"pmids\": [\"36542833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD53 directly binds PP2A or p130 not determined\", \"Whether this mechanism operates in other quiescent cell types unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Glycosylation and conformational state emerged as regulatory layers: N-glycosylation of CD53 inhibits partner interactions (CD45, CD20, CD37) without affecting surface expression, and a closed-conformation mutant (F44E) shows enhanced clustering and CD45 binding, establishing that CD53 function is dynamically tunable.\",\n      \"evidence\": \"Glycosylation-site mutants with dSTORM super-resolution microscopy and co-IP; F44E conformational mutant analysis\",\n      \"pmids\": [\"38031400\", \"39159818\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological signals that regulate CD53 glycosylation or conformational switching in vivo unknown\", \"No structural data for open versus closed CD53 conformations\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of CXCR4 as a CD53 interaction partner and demonstration that CD53 promotes CXCR4 signaling and internalization extended the receptor-stabilization paradigm to chemokine receptors and explained impaired B cell bone marrow homing in Cd53−/− mice.\",\n      \"evidence\": \"PLA for CD53–CXCR4; CXCR4 phospho-flow and internalization; in vivo homing assay in Cd53−/− mice\",\n      \"pmids\": [\"38363205\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD53 similarly modulates other chemokine receptors not tested\", \"Mechanism of CXCR4 internalization enhancement not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of a physiological extracellular ligand for CD53, the atomic structure of CD53 and its partner complexes, the signals controlling conformational switching in vivo, and whether the receptor-stabilization mechanism generalizes across all CD53 partners.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No physiological ligand identified\", \"No high-resolution structure available\", \"In vivo regulation of CD53 conformation and glycosylation state unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [3, 7, 8, 21, 22, 24, 26, 28]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [19, 22, 24, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 7, 8, 17, 22, 27, 29]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 4, 5, 11, 19, 20, 21, 22, 23, 24, 28, 30]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 4, 13, 14, 15, 21, 24, 26]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [9, 10, 22, 23]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [21, 26]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [14, 16]}\n    ],\n    \"complexes\": [\n      \"Tetraspanin-enriched microdomain (TEM)\",\n      \"MHC class II–tetraspanin complex\",\n      \"PP2A–p130/DREAM complex\"\n    ],\n    \"partners\": [\n      \"CD45\",\n      \"IL7R\",\n      \"CXCR4\",\n      \"SELL\",\n      \"ITGA4\",\n      \"CD81\",\n      \"RBL2\",\n      \"PPP2CA\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}